SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

HC Wainwright & Co. Maintains Buy on Navidea Biopharmaceutical, Raises Price Target to $6

HC Wainwright & Co. maintains Navidea Biopharmaceutical (AMEX:NAVB) with a Buy and raises the price target from $4 to $6.

Benzinga · 05/22/2020 16:54

HC Wainwright & Co. maintains Navidea Biopharmaceutical (AMEX:NAVB) with a Buy and raises the price target from $4 to $6.